1992
Bone graft and total hip arthroplasty A review
Huo M, Friedlaender G, Salvati E. Bone graft and total hip arthroplasty A review. The Journal Of Arthroplasty 1992, 7: 109-120. PMID: 1613516, DOI: 10.1016/0883-5403(92)90003-9.Peer-Reviewed Original Research
1990
Orthopaedic manifestations of sickle-cell disease.
Huo M, Friedlaender G, Marsh J. Orthopaedic manifestations of sickle-cell disease. The Yale Journal Of Biology And Medicine 1990, 63: 195-207. PMID: 2238715, PMCID: PMC2589295.Peer-Reviewed Original ResearchConceptsSickle cell diseaseOrthopaedic manifestationsMajor orthopaedic manifestationsSurgical treatment alternativesFirst case reportJoint sequelaeSerious complicationsClinical entityCase reportDisorder pathophysiologyAccurate diagnosisTreatment alternativesDiseasePathophysiologyOsteonecrosisManifestationsNumerous investigatorsSepsisArthritisMorbidityOsteomyelitisPainComplicationsSequelaePatients
1981
Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy
Prosnitz L, Lawson J, Friedlaender G, Farber L, Pezzimenti J. Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy. Cancer 1981, 47: 2793-2797. PMID: 7260869, DOI: 10.1002/1097-0142(19810615)47:12<2793::aid-cncr2820471206>3.0.co;2-a.Peer-Reviewed Original ResearchConceptsAvascular necrosisHodgkin's diseaseModality therapyDisease patientsHumeral head involvementAdvanced Hodgkin's diseaseHodgkin's disease patientsLong-term survivorsBilateral hip replacementPossible serious consequencesNinth patientComplete remissionCorticosteroid administrationCumulative incidenceCombination chemotherapyHead involvementModality programConsiderable disabilityLarge dosesPatientsHip replacementFemoral headChemotherapeutic agentsNecrosisChemotherapy